Food and Drug Administration, et al., Petitioners v. Alliance for Hippocratic Medicine, et al.

  1. March 22, 2024

    Up Next At High Court: Abortion, Jury Trials And Estate Tax

    The U.S. Supreme Court will hear oral arguments this week over the U.S. Food and Drug Administration's decision expanding access to popular abortion pill mifepristone as well as whether juries should determine a defendants' eligibility for repeat offender enhanced sentencing under the Armed Career Criminal Act and how long federal employees have to appeal adverse employment decisions.

  2. March 22, 2024

    High Court Mifepristone Battle Goes Beyond Abortion

    The first major abortion battle to reach the U.S. Supreme Court since the Dobbs decision is about a lot more than abortion.

  3. March 01, 2024

    CVS, Walgreens Receive FDA's OK To Dispense Abortion Drug

    Pharmacy giants CVS and Walgreens announced Friday that they have received federal certification to dispense the abortion drug mifepristone and will begin doing so soon in certain states — a development that President Joe Biden hailed as historic and that comes amid a larger battle in the U.S. Supreme Court.

  4. February 22, 2024

    Justices Urged To Affirm Limits On Mifepristone Access

    The Alliance for Hippocratic Medicine filed a brief in its U.S. Supreme Court case over the abortion medication mifepristone on Thursday, saying the U.S. Food and Drug Administration unlawfully rolled back various safeguards for accessing the pill, such as an in-person doctor's visit requirement.

  5. February 20, 2024

    High Court Blocks Bid By 3 States To Join Abortion Drug Case

    Republican attorneys general of three states on Tuesday lost in their attempt to join the U.S. Supreme Court case challenging approval of the abortion medication mifepristone, a potential blow to their efforts to ensure the case isn't dismissed for lack of standing.

  6. February 02, 2024

    ABA Chides 5th Circ. At High Court Over Mifepristone Ruling

    The American Bar Association on Friday urged the U.S. Supreme Court to undo a Fifth Circuit opinion affirming limits on access to the abortion medication mifepristone, saying it doesn't typically weigh in on such cases, but asserting the appeals court wrongly "second-guessed" the Food and Drug Administration.

  7. February 01, 2024

    Ex-FDA Leaders Urge High Court To Nix Mifepristone Ruling

    Seven former commissioners and acting commissioners of the U.S. Food and Drug Administration told the U.S. Supreme Court on Thursday that a Fifth Circuit decision reinstating some restrictions on mifepristone, a drug used to end early pregnancies and manage miscarriages, threatens the nation's drug approval process.

  8. January 30, 2024

    Scholars, Advocates Tell Justices Mifepristone Limits Must Go

    A mix of scholars, healthcare providers, lawmakers and abortion rights supporters filed three dozen amicus briefs Tuesday, urging the U.S. Supreme Court to reverse a Fifth Circuit decision that reinstated some restrictions on mifepristone, a drug used to end early pregnancies and manage miscarriages.

  9. January 29, 2024

    Justices To Hear Abortion Drug Case Arguments In March

    The U.S. Supreme Court is set to consider live arguments in a case that could determine the future availability of a widely used abortion medication, advancing a matter some regard as the most significant battle over abortion since the justices overruled Roe v. Wade.

  10. January 24, 2024

    Feds Ask Justices To Nix 5th Circ.'s Abortion Pill Limits

    The Biden administration has asked the U.S. Supreme Court to reverse a Fifth Circuit decision upholding a lower court's reinstatement of restrictions on access to the abortion medication mifepristone, saying that the case marks the first time any court has challenged the scientific judgment of U.S. Food and Drug Administration experts by restricting access to an FDA-approved drug.